-
Middle-aged, postmenopausal women with significant symptomatic vasomotor events (VMEs) experienced equivalent significant relief of symptoms after 3 months of treatment with a flaxseed-enriched or an isocaloric control whole wheat- and barley-enriched diet. The VMEs in each group of recently menopausal patients were measured by a validated global scale, the Kupperman Menopausal Index, and a vasomotor diary at a Brazilian public health clinic over 12 weeks.
-
Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
The single author of this small pilot study concludes that 50 mg of 5-HTP taken three times a day for 4 weeks is ineffective against menopausal hot flashes. The paper is disappointing in many ways, however, and readers might question whether the actual reason behind the trial was indeed to test 5-HTP.
-
A prospective study found that women gained weight at similar rates even though their physical activity levels varied substantially. Only women with normal BMI at baseline and higher levels of activity who maintained that activity level also maintained normal BMI.
-
An increase in dairy food intake produces significant and substantial suppression of oxidative and inflammatory stress associated with overweight and obesity.
-
Osteopathic manipulative treatment (OMT) is one of a number of CAM therapies often considered for the treatment of third trimester lower back pain (LBP). Results of this small trial suggest that manual therapy during late pregnancy may help improve back-specific functioning but has little impact on back pain. While OMT may be appropriate for some pregnant women experiencing LBP, unless the obstetrician is a DO such care requires additional appointments, and ultimately still may not offer significant pain relief.
-
Health care clinicians and organizations likely will find that the new health care reform bill's positive features outweigh its drawbacks, experts say.
-
-
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.
-
The promising results of this study suggest that timely supplementation with vitamin D3 may help prevent seasonal influenza A, though not influenza B, in school-aged children. A side finding was that children with asthma taking vitamin D3 experienced fewer exacerbations, though not a lesser rate of influenza A infection. I hope this trial will be replicated, and with measurement of 25-OH D levels, in both children and adults, to help tease out the role of vitamin D in flu prevention.
